Great post Needle! Thank you! Like I have said to others it would be interesting if only Big Pharma benefits from the Agile trials. The Executive Team and Executive Board of Agile have potential conflicts of interests such that the COO/CFO and President of the Executive Team work or worked closely with and for Big Pharma and the President has experience in acquisitions. Isn’t that interesting that there was this ambiguous announcement that shook investors despite no negative announcement for safety or efficacy. This ambiguous announcement is just to timely in my opinion.
- Forums
- ASX - By Stock
- Ann: Interim data from MSKCC study
Great post Needle! Thank you! Like I have said to others it...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)